ImpediMed Limited (ASX:IPD)
Australia · Delayed Price · Currency is AUD 0.0450
-0.0020 (-4.26%)
Aug 6, 2025, 4:10 PM AEST
ImpediMed Market Cap
ImpediMed has a market cap or net worth of 91.29 million as of August 5, 2025. Its market cap has decreased by -31.63% in one year.
Market Cap
91.29M
Enterprise Value
74.65M
Revenue
11.54M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.05
Market Cap Chart
Since October 24, 2007, ImpediMed's market cap has increased from 67.49M to 91.29M, an increase of 35.27%. That is a compound annual growth rate of 1.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2025 | 91.29M | -13.27% |
| Dec 31, 2024 | 105.26M | -64.12% |
| Dec 29, 2023 | 293.38M | 108.23% |
| Dec 30, 2022 | 140.90M | -54.66% |
| Dec 31, 2021 | 310.77M | 130.93% |
| Dec 31, 2020 | 134.57M | 60.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 129.38B |
| Pro Medicus | 32.75B |
| Cochlear | 20.52B |
| Sonic Healthcare | 13.66B |
| Ramsay Health Care | 8.66B |
| Telix Pharmaceuticals | 6.85B |
| Ansell | 4.43B |
| Mesoblast | 3.08B |